Jessica Ching is an industrial designer responsible for product development and the overall direction of Eve Medical. She has worked previously in product development and manufacturing liaison roles for Herman Miller, Umbra and Telus. She is a graduate of OCAD University, and also holds a BA in International Development from McGill University.
Evan Moses is responsible for operations at Eve Medical. Evan is a second-time entrepreneur and has experience in the management and coordination of complex projects with multiple stakeholders. He holds a BA in Political Science and Economics from McGill University and a MArch from the University of Toronto.
Sheldon Stevens has been the CFO for over a dozen companies over the past 11 years, including DNA Genotek and Privacy Analytics. Previously, Sheldon worked with Ernst & Young’s accounting and management consulting groups, and Deloitte Consulting. He was a founding shareholder of VOCI and UnCommon Grounds. Sheldon is a qualified Chartered Accountant.
Yasmine brings over 8 years of experience in end-to-end marketing to Eve Medical as Marketing Lead. She previously held positions at Match Marketing, Edelman and Apple Inc, and has worked with a number of recognized brands, including Pfizer, Cystic Fibrosis Canada, Mars Food and Pets, and ConAgra Foods. Yasmine has an MBA from Rotman School of Management and a Hons. BA in Psychology from York University.
Violeta manages Eve Medical’s customer relationships in Latin America, Spain and France. She has cancer research experience at the Université Pierre et Marie Curie in Paris, and has worked internationally in customer service roles. Violeta is a graduate of Universidad Autónoma de Madrid in Biology and Cognitive Sciences.
Michaela is responsible for quality management at Eve Medical. She has over 10 years experience within the medical device industry setting up Quality Management Systems and obtaining Health Canada, FDA, European and Australian regulatory approvals.
Brianne is a research associate with Eve Medical and has received a Mitacs Accelerate fellowship to investigate the role of HPV self-sampling as a cervical cancer screening strategy for Ontario. Brianne has a background in Epidemiology and Biostatistics and is currently pursuing her PhD in Epidemiology at the University of Ottawa. She has previously coordinated a study that compared self-sampling uptake with Pap test uptake in First Nations communities in Northwestern Ontario.
Norma Beauchamp is the President and CEO of Cystic Fibrosis Canada. An accomplished business and non-profit leader, Norma has over three decades of senior leadership positions in Canada and Germany. She held executive positions at Genzyme, Bayer and the Canadian Foundation for Women’s Health. As a three-time cancer survivor, Norma has been a passionate patient advocate in recent years and has worked with patient and healthcare organizations to enhance access to care. Norma completed the University of Toronto’s Rotman School of Management Directors Education Program (ICD.D) in 2009 and graduated from Bishop’s University with a Bachelor of Business Administration in Marketing.
Brian Hunter is the President of NorthSpring Capital Partners. A seasoned financial executive, Brian has broad experience in providing debt and equity financing to small and medium sized Canadian businesses. During his 30-year tenure with Roynat Capital, Canada’s leading private merchant bank, he was instrumental in completing numerous management and leveraged buyout transactions in a wide variety of industries. Brian earned his BA in Economics and his MBA at the University of Western Ontario. He has written on numerous business topics for The Financial Post and Exchange Magazine and recently co-authored a book on business turnarounds, “Turnaround: Brains, Guts and Stamina”. Brian is also very active in the community and is a member and past President of The Rotary Club of Kitchener-Conestoga.
Terry Mo has over 25 years’ experience in Asia, particularly in the Greater China Region. He has held senior executive positions in Fortune 500 companies in the chemicals, semiconductor and health care industries. Terry has an MBA in Finance and MS in Management from Rensselaer Polytechnic Institute, and a BS in Chemical Engineering from the University of Michigan. Read More
With 10 years experience in biotech, Melanie was instrumental in the early stage growth of DNA Genotek as they defined a new market for non-invasive sample collection. She has developed markets in North America and around the world and is currently Director of International Sales for APAC, EMEA and LATAM. She also had global market development responsibility for HLA registries. Melanie has an Honours Degree in Biopharmaceutical Sciences and is currently the Ottawa Co-Chair of Women Powering Technology, an organization created to inspire, support, elevate and empower women in technology personally, professionally and together as a community.
Prof. Attila Lorincz received a doctorate in genetics from Trinity College, University of Dublin, Ireland. While a research fellow at the University of California, Santa Barbara he was the first to report that yeast cdc28 is a protein kinase and the prototype of the human cell cycle cdk genes (Lorincz and Reed, Nature 1984). His human papillomavirus studies began in collaboration with Nobel Laureate Harald zurHausen and this work produced clones of many novel carcinogenic HPV types. In 1990 Dr Lorincz co-founded Digene Corp. (now QIAGEN Inc.) as Chief Scientific Officer. His research led to the Hybrid Capture (HC) series of tests, HC2 was the first HPV test to be FDA-approved for cervical pre-cancer screening and is widely regarded as the international reference standard. His subsequent research work includes the development of a simple robust HPV test for resource-limited regions and a randomized clinical trial to validate self-sampling as an efficient screening approach to prevent cervical cancer. Read More
Dr. Alexander has worked extensively in public health and women’s health. Most recently, she served as VP of Women’s Health and Global Advocacy at QIAGEN. In this role, she oversaw corporate women’s health program efforts in the public sector and advocacy support initiatives in global cervical cancer prevention. Her previous professional positions included serving as VP, Women’s Health at Digene and President and CEO of the American Sexual Health Association (ASHA). At ASHA she provided national leadership and worked in close partnership with industry and federal leaders to promote national awareness for all sexually transmitted diseases. Dr. Alexander is also a retired lieutenant colonel with the U.S. Army Nurse Corps. She is nationally known for her leadership in women’s health advocacy and has published extensively on women’s health issues. Read More
Dr. Charlotte Gaydos is a Professor in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She has joint appointments in the Emergency Medicine Department and at the Johns Hopkins School of Public Health, and is the director of the International Sexually Transmitted Diseases Research Laboratory. She has extensive laboratory expertise with over 40 years experience in microbiology. Dr. Gaydos runs iwantthekit, a program to reduce STI-related infertility through internet-enabled testing.
Dr. Diane Harper is internationally known researcher, clinician and educator in the field of HPV associated diseases, especially focused on the prevention of cervical cancer. She is the Director of the Gynecologic Cancer Prevention Research Group and is a Professor at the University of Missouri Kansas City School of Medicine. Dr. Harper has conducted research on barriers to screening and on HPV self-sampling and was a principal investigator for the clinical trials of both HPV vaccines, Cervarix and Gardasil.